Mimp/Mtch2, an Obesity Susceptibility Gene, Induces Alteration of Fatty Acid Metabolism in Transgenic Mice

Por Bar-Lev, Yamit, Moshitch-Moshkovitz, Sharon, Tsarfaty, Galia, Kaufman, Dafna, Horev, Judith, Resau, James H., Tsarfaty, Ilan
Publicado no PLoS One (2016)

HGF/SF Increases Tumor Blood Volume: A Novel Tool for the In Vivo Functional Molecular Imaging of Met

Por Tsarfaty, Galia, Stein, Gideon Y, Moshitch-Moshkovitz, Sharon, Kaufman, Dafna W, Cao, Brain, Resau, James H, Vande Woude, George F, Tsarfaty, Ilan
Publicado em 2006

In Vivo Direct Molecular Imaging of Early Tumorigenesis and Malignant Progression Induced by Transgenic Expression of GFP-Met

Por Moshitch-Moshkovitz, Sharon, Tsarfaty, Galia, Kaufman, Dafna W, Stein, Gideon Y, Shichrur, Keren, Solomon, Eddy, Sigler, Robert H, Resau, James H, Vande Woude, George F, Tsarfaty, Ilan
Publicado em 2006

Hepatocyte growth factor (HGF) autocrine activation predicts sensitivity to MET inhibition in glioblastoma

Por Xie, Qian, Bradley, Robert, Kang, Liang, Koeman, Julie, Ascierto, Maria Libera, Worschech, Andrea, De Giorgi, Valeria, Wang, Ena, Kefene, Lisa, Su, Yanli, Essenburg, Curt, Kaufman, Dafna W., DeKoning, Tom, Enter, Mark A., O'Rourke, Timothy J., Marincola, Francesco M., Vande Woude, George F.
Publicado em 2012

Monovalent antibody design and mechanism of action of onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agent

Por Merchant, Mark, Ma, Xiaolei, Maun, Henry R., Zheng, Zhong, Peng, Jing, Romero, Mally, Huang, Arthur, Yang, Nai-ying, Nishimura, Merry, Greve, Joan, Santell, Lydia, Zhang, Yu-Wen, Su, Yanli, Kaufman, Dafna W., Billeci, Karen L., Mai, Elaine, Moffat, Barbara, Lim, Amy, Duenas, Eileen T., Phillips, Heidi S., Xiang, Hong, Young, Judy C., Vande Woude, George F., Dennis, Mark S., Reilly, Dorothea E., Schwall, Ralph H., Starovasnik, Melissa A., Lazarus, Robert A., Yansura, Daniel G.
Publicado em 2013